LRP6 and Miyoshi myopathy: Importantly, anti‐LRP6 antibody treatment prevented reductions in bone strength in 5TGM1‐bearing mice as a result of protection against MM‐induced BV/TV loss (p < 0.01, Fig. 3Eiii), returning the maximum load to failure to naïve mouse isotype levels.